AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and ...
AstraZeneca beat third-quarter earnings expectations on Thursday, helped by strong sales of its cancer, heart and kidney ...
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based ...
Q3 revenues surpassed $15 billion thanks to soaring sales of cancer drugs. CEO Pascal Soriot told Market Sunrise host Ramzan ...
AstraZeneca reported its largest quarterly revenue ever, as soaring sales of cancer drugs helped the drugmaker beat ...
AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side ...
The pharmaceutical company posted a 14% on-year increase in third-quarter core earnings per share, while revenue rose to ...
AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, ...
AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a ...
British pharmaceutical giant AstraZeneca announced surging quarterly profit Thursday on strong sales of cancer drugs and as ...
The Alliance for Building Better Medicine (ABBM) and the Virginia Innovation Partnership Corporation (VIPC) celebrated Governor Glenn Youngkin's announcement of $120 million in private industry ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback